Cancer Researchers Convene in Chicago for ASCO's Annual Meeting
Article date: May 30, 2008
This weekend top cancer researchers and physicians head to the Windy City for the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 30th through June 3rd.
More than 4,000 abstracts will be presented on a range of topics, with special sessions on the latest in breast cancer research and genetics.
ASCO's Annual Meeting is one of the largest cancer-related conferences in the country, and over 30,000 attendees are expected this year. Previous years have seen major announcements, including 2005's breakthrough discovery that Herceptin is effective in treating early-stage breast cancer patients.
Click the links below to learn more about some of the studies being discussed during this year's conference.
News from ASCO
June 2, 2008
Results from two pioneering studies from Duke University Medical Center offer hope to patients with one of the deadliest forms of brain cancer.
A Duke research team has found that most patients who had surgery for non-small cell lung cancer were able to tolerate moderate exercise within a month of their operation and were less fatigued and gained greater fitness as a result. The findings will be discussed in a poster presentation.
A new study suggests breast cancer patients might fare worse if they don't have enough vitamin D in their blood. Scientists from University of Toronto are scheduled to present their work at the meeting.
Reviewed by: Members of the ACS Medical Content Staff
ACS News Center stories are provided as a source of cancer-related news and are not intended to be used as press releases.
Thank you for your feedback.